# RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
Canonical URL: https://biopharmsignal.com/news/RXST/rxsight-inc-reports-fourth-quarter-and-2025-results-issues-2026-guidance
Ticker: RXST
Company: RxSight
Source: RxSight
Published: 2026-02-25 21:05 EST
Original Source URL: https://investors.rxsight.com
## Summary

ALISO VIEJO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter and full year ended December 31, 2025. Strategic Highlights and Recent Developments 2025 Light Adjustable Lens (LAL ® and LAL+ ®) unit sales increased 12% to 109,615

## Article Body
ALISO VIEJO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter and full year ended December 31, 2025. Strategic Highlights and Recent Developments 2025 Light Adjustable Lens (LAL ® and LAL+ ®) unit sales increased 12% to 109,615
## Recent Company News
- 2026-05-19 20:10 EST — [RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum) — Source: RxSight
- 2026-05-06 20:05 EST — [RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook](https://biopharmsignal.com/news/RXST/rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook) — Source: RxSight
- 2026-04-29 20:10 EST — [RxSight, Inc. to Present at the Bank of America Healthcare Conference](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-bank-of-america-healthcare-conference) — Source: RxSight
- 2026-04-22 20:10 EST — [RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6](https://biopharmsignal.com/news/RXST/rxsight-inc-to-report-first-quarter-2026-financial-results-on-may-6) — Source: RxSight
- 2026-04-08 20:05 EST — [RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026](https://biopharmsignal.com/news/RXST/rxsight-highlights-300-000-light-adjustable-lens-implant-milestone-and-strong-scientific-presence-at-ascrs-2026) — Source: RxSight
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)